AQUA BIO TECHNOLOGY ASA – MINUTES FROM EXTRAORDINARY GENERAL MEETING – UPDATE ON FINANCING

Aqua Bio Technology ASA ("ABTEC" or the "Company") has today, on 9 April 2025, held an extraordinary general meeting. All resolutions were made in accordance with the proposals of the Company's Board of Directors. The minutes of the extraordinary general meeting are attached to this notice.

In connection with the general meeting, the Company has also received a proposal from an investor group for a further equity investment into the Company at the same price per share as in the private placement announced as placed on 11 March 2025. The Company's Board will review and discuss this proposal and provide further information in due course.

DISCLOSURE REGULATION

For further information, please contact Fredrik Henriksen, CEO, Phone +47 900 20 078.

Aqua Bio Technology (ABT) is developing and commercializing sustainable biotechnology for use in skin care products. ABT's cosmetics ingredients are highly effective and they provide the cosmetics industry with natural alternatives to traditional ingredients. ABT is also marketing and distributing

natural skin care products developed by partners towards consumers and professional users. Aqua Bio Technology is listed on Euronext Expand.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.